RxDoctor Payments Data

Russell Tigges, MD

Adult Reconstructive Orthopaedic Surgery · Poughkeepsie, NYNPI 1902839327

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (46.9%), travel and lodging and royalties or licence payments — rather than concentrated in one kind of arrangement. Heron Therapeutics, Inc. accounts for 76.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $48,918 and has fallen 85.9% since, to $6,898 in 2025.

$139,905in general payments, 2019–2025

Across 160 payments — averaging $874.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heron Therapeutics, Inc.$107K
  • Encore Medical, LP$32K
  • Pacira Pharmaceuticals Incorporated$679
  • Sanara Medtech Inc.$199
  • Stryker$126
  • Johnson & Johnson$124
  • plus $503 from 9 others
$2,910in research payments, 2019–2025

Across 1 payment — averaging $2910.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Maxx Orthopedics, Inc.$3K

What the payments were for

  • Royalty or licence$26,03019%
  • Consulting fees$12,8509%
  • Speaking & faculty fees$65,55047%
  • Travel & lodging$31,69323%
  • Food & beverage$3,7823%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$139,905 in reported general payments places this provider in the 80th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$786,839
Medicare patients
709
Services billed
24,941

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam907$2,625
Mupirocin215$1,333
Oxycodone Hcl88$526
Ketorolac Tromethamine16$185
Amoxicillin33$137
Prednisone31$122
Dexamethasone28$105
Tramadol Hcl24$55
Clindamycin Hcl11$53

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Poughkeepsie

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →